≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_BLADDER_EXALLC for full statistics.

Carcinoma in situ, bladder

DOID Endpoint Browser

CD2_INSITU_BLADDER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_BLADDER
517355

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D09.0&
  • Hospital discharge: ICD-9 — 2337
  • Cause of death: ICD-10 — D09.0&
  • Cause of death: ICD-9 — 2337
  • Cancer registry: Topography ICD-O-3 — C67
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

1071

4. Check minimum number of events

None

1071

5. Include endpoints

None

1071

6. Filter based on genotype QC (FinnGen only)

1071

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D09

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1071 200 871
Unadjusted period prevalence (%) 0.33 0.07 0.38
Median age at first event (years) 71.53 68.62 72.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
990
Matched controls
9898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
77.4
323.0
406
88
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
131.3
323.0
577
104
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
9553.9
323.0
711
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
139.2
323.0
493
70
KCD02
NOMESCO Finland
Transurethral resection of bladder
126.9
323.0
660
153
UKC02
NOMESCO Finland
Cystoscopy
277.0
323.0
971
1533
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
135.3
323.0
634
128
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
66.7
259.7
297
63
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
70.2
252.0
286
57
R31
ICD-10 Finland
Unspecified haematuria
12.1
247.7
551
927
ZX136
NOMESCO Finland
Intravesicalis
61.8
149.7
174
34
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
+∞
138.9
130
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
40.4
129.0
163
48
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
27.2
106.7
149
64
WX320
NOMESCO Finland
Spinalanesthesy
4.6
99.6
464
1590
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
+∞
82.5
78
*
XKD00
NOMESCO Finland
Uroflowmetry
3.5
68.5
446
1881
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.6
63.2
371
1421
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.9
63.0
192
385
U06
ICPC
Haematuria
9.2
55.6
121
147
TKC20
NOMESCO Finland
Catheterisation of bladder
4.7
54.6
207
525
KCW96
NOMESCO Finland
Other operations on bladder
26.9
54.2
75
30
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
19.1
52.4
81
46
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
51.7
411
1898
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
38.5
51.3
65
18
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
17.5
50.9
81
50
WX224
NOMESCO Finland
Blockade of obturius nerve
156.9
43.1
45
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
82.2
42.2
47
6
UKB02
NOMESCO Finland
Retrograde ureteroscopy
15.1
38.2
64
45
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
37.8
206
703
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
34.4
35.6
46
14
N30.0
ICD-10 Finland
Acute cystitis
3.6
34.2
169
531
KH1AD
NOMESCO Finland
CT of urinary organs
6.1
34.1
97
173
WX402
NOMESCO Finland
General anaesthesia
2.9
32.6
225
899
4CX01
NOMESCO Finland
NA
74.4
32.1
36
5
J01MA02
ATC
ciprofloxacin; systemic
2.2
31.9
505
3144
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
117.2
31.9
34
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.2
28.6
71
105
ZXC20
NOMESCO Finland
Use of chemical agents
6.5
27.9
75
124
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
27.5
247
1142
ZXE00
NOMESCO Finland
One hour or less
2.1
25.4
444
2792
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
7.7
23.5
55
75
C66
ICD-10 Finland
Malignant neoplasm of ureter
37.3
23.1
29
8
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
23.0
22
*
KED22
NOMESCO Finland
Transurethral resection of prostate
2.8
22.8
161
640
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
7.2
22.8
56
82
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.2
22.7
51
65
R33
ICD-10 Finland
Retention of urine
2.7
22.3
173
725
A98
ICPC
Health maint/preventive medicine
3.1
22.2
926
8156
U76
ICPC
Malignant neoplasm of bladder
35.9
22.1
28
8
G04BD12
ATC
mirabegron; oral
2.7
21.9
168
700
KCB00
NOMESCO Finland
Biopsy of bladder
20.6
21.8
32
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
21.4
187
839
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
12.3
21.2
38
32
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
42.6
20.5
25
6
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
13.5
19.8
34
26
KCC10
NOMESCO Finland
Cystoprostatectomy
12.1
18.9
34
29
G04CA02
ATC
tamsulosin; oral
1.8
18.4
444
3028
KDV10
NOMESCO Finland
Internal urethrotomy
6.1
17.9
49
84
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
12.8
17.7
31
25
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
13.4
17.5
30
23
N02BE01
ATC
paracetamol; systemic, rectal
2.1
17.5
846
7269
KH1DD
NOMESCO Finland
CT urography of urinary organs
29.4
17.5
23
8
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.7
17.4
50
91
JN4AD
NOMESCO Finland
Body CT examination
2.7
17.3
127
513
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
16.7
16
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
40.8
16.4
20
5
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.2
16.2
39
56
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
17.1
16.1
25
15
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.7
16.0
54
119
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
81.3
14.6
16
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
14.5
389
2684
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
14.3
106
430
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
22.6
14.2
20
9
J01MA12
ATC
levofloxacin; systemic
1.9
13.7
234
1386
J01EA01
ATC
trimethoprim; systemic
1.9
13.4
209
1197
WZC30
NOMESCO Finland
Teaching
2.1
13.2
157
803
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
13.1
317
2102
KBH20
NOMESCO Finland
Replantation of ureter
50.7
12.9
15
*
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
12.5
12
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
6.4
12.5
32
51
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.5
490
3714
SPAT1263
SPAT
Sampling
1.7
12.4
413
2992
B02AA02
ATC
tranexamic acid; systemic
2.5
12.4
103
445
J01DB01
ATC
cefalexin; oral
1.7
12.4
761
6510
SPAT1167
SPAT
Insertion of urinary catheter
3.0
11.7
68
238
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.7
381
2731
KBV10
NOMESCO Finland
Removal of stent from ureter
9.8
11.3
22
23
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.3
11.0
40
96
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.6
10.7
36
80
KC1GB
NOMESCO Finland
Cystography with X-ray
5.4
10.6
31
59
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
111.1
10.4
11
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.0
10.4
59
203
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
32.9
10.3
13
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
23.6
10.3
14
6
SPAT1312
SPAT
General health counselling
1.6
9.9
293
2028
U29
ICPC
Urinary symptom/complaint other
3.7
9.8
42
118
U07
ICPC
Urine symptom/complaint other
2.5
9.5
74
309
KCD30
NOMESCO Finland
Destruction of tumour of bladder
17.7
9.4
14
8
KBD00
NOMESCO Finland
Partial excision of ureter
30.3
9.4
12
*
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
3.5
9.2
41
120
G04CA01
ATC
alfuzosin; oral
1.7
9.1
207
1327
KA3EB
NOMESCO Finland
Antegrade pyelography
10.1
9.0
17
17
WX110
NOMESCO Finland
Local anesthesy
1.5
9.0
578
4771
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
8.8
420
3240
S18
ICPC
Laceration/cut
1.5
8.7
416
3212
R39.1
ICD-10 Finland
Other difficulties with micturition
2.9
8.7
52
188
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
8.3
8.6
18
22
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
8.3
61
249
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.2
8.2
24
47
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
8.1
73
328
U05
ICPC
Urination problems other
2.4
8.1
68
297
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
11.8
8.1
14
12
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
17.3
8.1
12
7
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.1
221
1486
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.9
7.9
47
169
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
7.8
155
951
KGH10
NOMESCO Finland
Operation for phimosis
3.0
7.8
42
143
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.7
311
2298
WX702
NOMESCO Finland
Supraglottic ventilation device
2.7
7.6
50
192
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.6
128
746
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
7.6
372
2862
U01
ICPC
Dysuria/painful urination
2.5
7.5
55
224
SPAT1301
SPAT
No procedures
1.5
7.4
298
2198
U02
ICPC
Urinary frequency/urgency
1.9
7.3
102
556
RD211
NOMESCO Finland
NA
2.8
7.2
46
172
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
7.4
7.2
16
22
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
30.2
7.2
9
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
7.2
54
225
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
10.1
7.0
13
13
G04BD08
ATC
solifenacin; oral
2.0
6.9
83
426
KBV00
NOMESCO Finland
Insertion of stent into ureter
6.8
6.8
16
24
A02BC02
ATC
pantoprazole; systemic
1.4
6.8
603
5164
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.6
6.8
165
1071
JN4BD
NOMESCO Finland
Extensive body CT
1.7
6.8
136
839
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
6.5
78
402
KAC20
NOMESCO Finland
Nephroureterectomy
14.4
6.4
10
7
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.3
433
3519
KA1FN
NOMESCO Finland
Isotope renography
6.0
6.3
16
27
Z3231
NOMESCO Finland
Registered nurse
1.5
6.3
268
1987
SPAT1153
SPAT
Removal of sutures
1.4
6.3
320
2459
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
6.3
6
*
B01AB05
ATC
enoxaparin; parenteral
1.5
6.2
290
2194
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.6
6.1
179
1220
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
327
2534
R30.0
ICD-10 Finland
Dysuria
2.8
6.1
36
131
N30
ICD-10 Finland
Cystitis
2.6
6.1
43
173
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
6.0
105
620
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.0
271
2031

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
852
553
71.46
307.65
7.4
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
540
1191
8.13
261.47
1.9
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
861
3695
7.78
188.89
10.1
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
723
2715
6.12
182.93
6.0
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
602
2157
5.09
154.45
6.7
2.6
e6/l
3.5
3.5
0.01
562
1907
(40768804) Tissue Pathology biopsy report
770
3444
5.40
146.45
3.3
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
691
3088
4.49
124.70
11.4
3.5
e6/l
531.6
101.9
1.66
636
2468
(3030467) Casts [#/volume] in Urine by Automated count
637
2802
4.14
114.63
10.6
3.4
e6/l
0.2
0.5
7.94
561
2184
(3031040) Bacteria [#/volume] in Urine by Automated count
985
6002
8.98
114.22
14.8
4.6
e6/l
55.8
1182.2
0.98
24
112
(3018095) Leukocytes [#/volume] in Urine
710
3426
4.18
110.33
12.4
3.9
e6/l
161.0
119.8
0.45
660
2599
(36304419) Bacteria [Presence] in Urine
596
2662
3.79
101.30
10.4
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
974
6155
7.43
100.26
10.1
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
485
2053
3.49
86.37
7.2
2.9
mosm/kgh2o
585.8
578.1
0.40
447
1742
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
741
4347
3.29
71.58
5.9
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
416
1766
3.22
71.03
9.7
3.0
e6/l
1.0
1.0
0.05
347
1084
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
393
1679
3.12
65.46
10.7
3.2
e6/l
1.1
1.1
0.02
324
1004
(3021601) Nitrite [Presence] in Urine by Test strip
695
4228
2.83
57.22
8.2
5.0
estimate
0.0
0.0
0.00
190
823
(3035350) Ketones [Presence] in Urine by Test strip
696
4261
2.81
56.17
6.4
3.8
estimate
0.0
0.0
0.00
191
814
(3009261) Glucose [Presence] in Urine by Test strip
699
4304
2.80
55.50
6.4
3.8
estimate
0.0
0.0
0.00
182
784
(40761535) Cells panel - Urine sediment
228
857
3.11
45.55
6.7
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
528
3046
2.45
44.56
3.2
2.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
813
5723
2.75
44.29
5.9
5.3
mmol/l
6.9
6.9
0.27
789
5409
(3030981) Hyaline casts [#/volume] in Urine by Automated count
175
604
3.27
40.05
8.4
2.8
e6/l
0.2
0.3
1.74
175
596
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1007
8482
4.13
30.62
23.9
18.2
mg/l
31.7
28.8
1.59
878
6957
(3041096) Erythrocytes [Presence] in Urine by Automated
391
2240
2.17
30.61
6.0
3.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
638
4472
2.06
28.31
12.9
11.8
inr
1.3
1.4
0.80
201
1210
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
967
8038
3.09
28.22
26.0
17.1
ml/min/173m2
70.8
73.9
4.59
885
6704
(3019550) Sodium [Moles/volume] in Serum or Plasma
1038
9023
5.88
28.15
29.9
21.7
mmol/l
139.5
139.6
0.66
1022
8789
(3023368) Bacteria identified in Blood by Culture
497
3201
2.03
27.76
5.0
4.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1038
9039
5.81
27.72
30.2
21.9
mmol/l
4.0
4.0
0.69
1021
8800
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
500
3295
1.97
25.51
7.2
4.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
1043
9219
6.02
24.97
36.6
26.5
fl
91.9
91.9
0.02
1030
9046
(3035941) MCH [Entitic mass]
1043
9219
6.02
24.97
36.6
26.4
pg
30.4
30.6
1.99
1030
9044
(3007461) Platelets [#/volume] in Blood
1043
9219
6.02
24.97
36.7
26.5
e9/l
237.4
232.1
1.88
1019
8938
(3026361) Erythrocytes [#/volume] in Blood
1043
9220
6.02
24.95
36.8
26.5
e12/l
4.4
4.4
1.23
1017
8903
(3000963) Hemoglobin [Mass/volume] in Blood
1043
9222
6.01
24.89
37.0
26.7
g/l
132.7
135.1
4.68
1030
9047
(3010813) Leukocytes [#/volume] in Blood
1043
9222
6.01
24.89
36.8
26.6
e9/l
7.2
7.0
3.78
1017
8905
(40761511) CBC panel - Blood by Automated count
1005
8673
3.58
24.76
24.2
17.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
869
7023
2.26
24.12
9.3
8.2
u/l
78.7
80.8
0.81
824
6594
(40761536) Microorganisms panel - Urine sediment
167
765
2.40
21.56
6.1
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
659
4937
1.87
21.15
7.3
6.8
umol/l
10.7
12.7
8.85
632
4705
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
752
5883
1.93
21.03
5.9
5.5
ug/l
2.7
3.3
0.94
673
5228
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
373
2365
1.89
20.17
3.3
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
356
2225
1.90
20.12
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
378
2415
1.87
19.91
7.3
4.1
estimate
0.0
0.0
0.50
171
761
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1013
8988
3.35
19.63
12.9
11.7
u/l
25.3
26.2
1.11
973
8616
(3013707) Erythrocyte sedimentation rate by Westergren method
786
6417
1.85
17.07
4.3
4.2
mm/h
16.1
13.9
2.53
699
5844
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
636
4884
1.74
17.04
8.0
7.5
mmol/l
1.2
1.2
0.75
528
4108
(3011397) Hemoglobin [Presence] in Urine by Test strip
323
2053
1.82
16.75
6.2
3.7
—
—
—
0
0
(4035726)
164
833
2.14
16.31
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
201
1110
2.00
15.93
5.0
3.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
566
4274
1.69
15.53
6.1
5.2
g/l
34.2
34.5
0.73
527
3967
(3009542) Hematocrit [Volume Fraction] of Blood
854
7233
1.89
15.52
25.6
19.7
%
39.3
39.1
0.18
489
4434
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
531
3943
1.69
15.52
2.5
2.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
360
2411
1.74
15.37
4.9
4.3
%
84.1
81.9
0.87
355
2357
(3044889) 12 lead EKG panel
775
6403
1.76
14.94
5.2
4.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
644
5073
1.68
14.68
9.6
9.2
e9/l
4.6
4.4
1.67
556
4416
(3013512) EKG study
426
3026
1.68
14.43
5.2
4.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
581
4477
1.65
14.26
7.2
6.5
mmol/l
1.2
1.2
0.76
519
4042
(3014576) Chloride [Moles/volume] in Serum or Plasma
240
1466
1.82
13.82
7.7
7.0
mmol/l
105.2
104.2
2.82
235
1427
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
946
8393
2.09
13.63
5.7
5.2
mmol/l
6.3
6.2
1.83
816
7499
(3019069) Monocytes/100 leukocytes in Blood
540
4146
1.61
12.97
6.2
6.4
%
9.0
9.2
0.48
499
3867
(3006504) Eosinophils/100 leukocytes in Blood
537
4131
1.60
12.69
6.0
6.1
%
2.7
2.9
0.56
498
3841
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
407
2931
1.63
12.63
3.2
2.6
u/l
55.5
57.6
0.67
381
2711
(3002030) Lymphocytes/100 leukocytes in Blood
545
4211
1.60
12.62
6.1
6.3
%
24.4
25.5
1.51
504
3909
(3018010) Neutrophils/100 leukocytes in Blood
536
4138
1.59
12.36
5.8
6.0
%
59.9
58.8
1.26
502
3862
(42870588) Differential panel, method unspecified - Blood
425
3112
1.61
12.22
5.1
5.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
280
1848
1.70
12.12
2.0
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
144
775
1.99
12.11
4.6
3.8
kpa
5.1
5.1
0.27
136
712
(3022096) Basophils/100 leukocytes in Blood
523
4029
1.58
12.07
6.0
6.0
%
0.6
0.6
1.29
486
3756
(3009343) pH of Capillary blood
142
763
1.99
11.99
4.6
3.8
ph
7.4
7.4
0.12
16
90
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
137
728
2.01
11.93
4.4
3.8
mmol/l
1.0
1.9
2.30
108
539
(3045414) Leukocytes [Presence] in Urine
87
386
2.36
11.91
3.6
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
864
7535
1.76
11.84
4.7
4.3
mu/l
2.0
2.1
0.94
735
6701
(3002385) Erythrocyte distribution width [Ratio]
788
6731
1.65
11.39
31.3
22.1
%
14.0
13.9
1.31
774
6581
(3013115) Eosinophils [#/volume] in Blood
571
4527
1.56
11.36
5.6
5.9
e9/l
0.2
0.2
0.01
493
3947
(3006315) Basophils [#/volume] in Blood
554
4395
1.54
10.76
5.5
5.8
e9/l
0.0
0.0
0.40
470
3762
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
132
721
1.95
10.60
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
108
555
2.05
10.29
4.9
3.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
421
3170
1.54
10.23
3.4
3.4
mg/l
210.4
271.8
0.15
297
2143
(3009508) Creatinine [Moles/volume] in Urine
423
3208
1.53
9.85
3.3
3.3
mmol/l
7.5
7.8
1.09
331
2647
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
924
8332
1.79
9.83
5.1
4.9
mmol/l
4.2
4.3
2.00
799
7581
(3001604) Monocytes [#/volume] in Blood
546
4378
1.50
9.69
5.5
5.7
e9/l
0.7
0.6
1.22
462
3734
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
360
2646
1.54
9.64
2.6
2.2
mg/l
3.1
3.1
0.11
305
2248
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
941
8550
1.83
9.50
5.7
5.5
mmol/l
2.4
2.5
2.55
813
7716
(3021589) Normoblasts [#/volume] in Blood
488
3848
1.49
9.25
14.3
10.6
e9/l
0.0
0.0
0.31
405
3145
(3020682) Albumin/Creatinine [Ratio] in Urine
435
3355
1.50
9.17
4.3
4.1
mg/mmol
11.0
9.6
0.21
298
2230
(3019198) Lymphocytes [#/volume] in Blood
552
4474
1.48
9.05
5.6
5.9
e9/l
1.9
1.9
0.12
482
3905
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
581
4765
1.48
8.93
5.2
4.7
%
20.7
21.7
0.85
330
2547
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
911
8241
1.71
8.82
5.0
4.8
mmol/l
1.3
1.4
3.40
782
7419
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
26
5.84
8.34
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
902
8173
1.66
8.25
7.7
6.7
mmol/mol
42.1
41.1
2.32
805
7447
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
178
1149
1.66
8.09
3.7
4.3
ug/l
24.7
28.1
0.07
148
980
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
694
5966
1.46
7.90
3.9
3.4
pmol/l
15.0
15.0
0.07
580
5257
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
883
7988
1.60
7.80
4.5
4.3
mmol/l
1.4
1.3
3.23
749
7145
(3014051) Protein [Presence] in Urine by Test strip
52
225
2.38
7.58
4.9
2.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
14
25
5.66
7.55
2.2
2.1
nmol/l
2.2
9.6
0.44
14
20
(3022621) pH of Urine by Test strip
110
634
1.82
7.46
4.5
3.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
28
89
3.20
7.30
1.5
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
81
431
1.95
7.02
2.2
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
424
3380
1.42
6.99
3.5
3.3
ug/l
0.7
0.8
0.41
323
2438
(3018418) pH of Serum or Plasma
368
2871
1.43
6.80
4.5
4.4
ph
7.4
7.4
0.07
85
550
(3000330) Specific gravity of Urine by Test strip
94
533
1.84
6.73
8.0
3.9
—
—
—
0
0
(3019225) pH of Specimen
156
1019
1.62
6.72
5.9
4.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
604
5149
1.40
6.61
3.2
3.4
u/l
56.1
60.6
0.49
550
4719
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
81
446
1.88
6.36
4.4
2.6
u/ml
0.3
0.4
0.46
47
249
(3021960) Folate [Moles/volume] in Serum or Plasma
331
2559
1.42
6.35
1.6
1.6
nmol/l
19.1
19.4
0.15
270
2180
(3004789) Transferrin [Mass/volume] in Serum or Plasma
218
1559
1.50
6.27
3.1
2.7
g/l
2.3
2.2
1.26
195
1448
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
56
272
2.12
6.25
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
143
932
1.62
6.20
8.6
8.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
393
3148
1.39
6.09
4.1
3.4
mmol/l
2.3
2.3
0.19
328
2694
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
209
1493
1.50
6.02
3.2
2.7
%
18.8
22.8
4.18
175
1281
(3021901) Oxygen saturation in Capillary blood
50
236
2.17
6.00
2.4
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
184
1284
1.52
5.92
1.8
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
416
3377
1.38
5.90
3.4
3.3
ng/l
2518.2
1844.9
0.89
367
2993
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
80
450
1.84
5.89
3.5
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
497
4159
1.36
5.80
2.2
2.1
pmol/l
91.9
91.7
0.05
278
2321
(3042936) Bacteria identified in Isolate by Culture
209
1509
1.48
5.69
2.0
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
102
625
1.70
5.62
8.6
10.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
82
472
1.80
5.61
2.3
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
125
808
1.62
5.60
4.3
4.2
mmol/l
1.2
1.2
1.22
105
709
(3015235) Bicarbonate [Moles/volume] in Capillary blood
62
327
1.95
5.56
3.4
3.2
mmol/l
23.9
24.9
1.10
54
278
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
407
3317
1.37
5.55
2.1
2.1
nmol/l
79.5
77.4
0.61
335
2879
(3022217) INR in Platelet poor plasma by Coagulation assay
217
1588
1.46
5.51
31.8
29.5
inr
1.4
1.5
0.55
39
217
(3001122) Ferritin [Mass/volume] in Serum or Plasma
425
3492
1.36
5.49
3.4
2.9
ug/l
159.3
179.5
0.90
373
3173
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
116
742
1.63
5.43
8.4
9.1
%
1.2
1.3
0.63
116
736
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
104
647
1.67
5.42
1.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
180
1273
1.50
5.42
1.8
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
155
1063
1.54
5.39
4.2
3.9
mmol/l
1.2
2.0
1.96
118
852
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
115
736
1.63
5.37
8.6
9.2
%
0.5
0.7
3.38
115
730
(3052851) Hemolysis interference index of Serum or Plasma
57
297
1.97
5.30
4.1
3.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
155
1070
1.52
5.23
6.8
7.5
mmol/l
10.6
11.2
0.47
146
1012
(3012501) Base excess in Blood by calculation
49
243
2.07
5.22
3.5
5.3
mmol/l
2.5
2.3
0.16
29
159
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
472
3977
1.33
5.03
5.4
4.2
ng/l
44.4
68.7
1.08
403
3147
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
56
296
1.94
5.01
2.2
2.4
ug/min
203.1
115.3
0.29
32
177
(1616796) Gas panel - Central venous blood
50
254
2.02
5.00
2.9
4.0
—
—
—
0
0
(3012544) pH of Venous blood
157
1101
1.50
4.91
4.3
3.9
—
7.4
—
0
8
(3022145) Colonoscopy Study observation
141
967
1.53
4.90
1.4
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
156
2.29
4.86
1.3
1.3
u/l
8.9
7.6
0.32
28
121
(3022948) Iron [Moles/volume] in Serum or Plasma
224
1688
1.41
4.80
3.2
2.7
umol/l
11.1
12.4
1.74
205
1568
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
23
84
2.78
4.80
1.1
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
141
974
1.52
4.74
1.9
2.3
g/l
0.2
0.2
0.93
130
899
(3035637) Corticotropin [Mass/volume] in Plasma
26
103
2.56
4.65
1.5
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
313
1.87
4.58
1.6
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
106
693
1.59
4.55
4.7
4.5
%
2.9
0.5
0.40
30
215
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
87
2.68
4.51
1.0
1.3
nmol/l
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
193
1433
1.42
4.48
6.5
6.2
mmol/l
1.0
1.0
0.03
181
1325
(3006184) Hemoglobin [Mass/volume] in Capillary blood
47
244
1.97
4.46
1.8
2.4
g/l
124.9
128.8
0.36
34
183
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
82
509
1.66
4.34
4.7
4.2
mmol/l
23.5
24.1
0.88
70
461
(3026493) Urate [Moles/volume] in Serum or Plasma
326
2650
1.33
4.30
3.1
3.1
umol/l
7148.8
7101.4
0.00
257
2253
(40767503) Oxygen content in Capillary blood by calculation
46
244
1.92
4.12
2.3
2.7
%
15.6
15.7
0.07
25
128
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
233
1811
1.37
4.11
1.7
1.7
mg/l
1.6
1.5
0.19
180
1429
(3042631) Mycobacterium sp identified in Specimen
34
165
2.10
3.90
2.9
2.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
186
1409
1.39
3.83
2.8
2.6
%
1.8
1.8
0.28
166
1252
(3045424) Erythrocytes [Presence] in Urine
29
133
2.21
3.82
1.4
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
180
1359
1.39
3.78
7.3
7.4
kpa
5.0
5.1
0.58
174
1289
(3003396) Base excess in Arterial blood by calculation
180
1360
1.39
3.76
7.3
7.4
mmol/l
0.2
1.1
2.65
145
1042
(3027801) Oxygen [Partial pressure] in Arterial blood
180
1360
1.39
3.76
7.2
7.4
kpa
12.0
11.8
0.21
173
1293
(40768797) Stomach Pathology biopsy report
164
1221
1.41
3.74
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
108
743
1.50
3.72
4.5
4.5
%
0.2
0.1
0.47
34
258
(3007853) Bacteria identified in Skin by Aerobe culture
157
1162
1.41
3.70
1.9
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
361
3027
1.29
3.70
2.5
2.2
u/l
211.5
256.1
0.35
331
2819
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
254
2040
1.32
3.56
4.4
4.1
ng/l
500.7
373.5
0.21
218
1773
(3012095) Magnesium [Moles/volume] in Serum or Plasma
215
1689
1.34
3.51
4.0
3.4
mmol/l
0.8
0.8
0.02
200
1582
(3002179) Metamyelocytes/100 leukocytes in Blood
103
712
1.49
3.48
4.6
4.3
%
0.9
0.6
0.73
29
200
(3017181) Myelocytes/100 leukocytes in Blood
113
799
1.46
3.41
4.8
4.4
%
0.9
0.8
0.12
35
284
(3019150) Specific gravity of Urine by Refractometry
239
1921
1.31
3.32
8.1
4.1
kg/l
1.0
1.0
0.06
35
288
(3036481) Cortisol [Moles/volume] in Serum or Plasma
108
762
1.46
3.30
3.6
2.3
nmol/l
350.4
369.2
0.36
102
696
(3026389) Candida sp identified in Specimen by Organism specific culture
22
97
2.29
3.21
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
22
97
2.29
3.21
3.5
3.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
172
1334
1.34
3.05
3.2
4.3
u/l
222.7
254.0
3.42
162
1256
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
116
844
1.42
3.02
2.6
2.4
u/l
32.2
36.6
0.66
103
719
(3028271) Lactate [Moles/volume] in Capillary blood
34
184
1.88
2.94
1.8
2.0
mmol/l
1.6
1.7
0.51
34
179
(3012565) Volume of 24 hour Urine
13
47
2.79
2.82
1.5
3.3
ml
1712.9
2014.1
—
7
39
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
23
3.94
2.77
2.3
2.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
140
1068
1.36
2.77
2.4
2.8
e9/l
62.8
69.4
1.37
110
848
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
142
1087
1.35
2.74
2.7
2.9
umol/l
9.0
10.6
0.24
129
976
(3051651) Icteric interference index of Serum or Plasma
15
60
2.52
2.71
3.5
3.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
28
148
1.92
2.62
2.0
1.9
%
88.8
89.1
0.10
28
148
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
267
2239
1.26
2.61
1.8
1.8
pmol/l
431.2
10217806.5
1.00
201
1840
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
106
782
1.39
2.58
3.4
3.2
ml/min/173m2
55.8
61.0
0.72
45
333
(3023323) Follitropin [Units/volume] in Serum or Plasma
15
62
2.44
2.54
1.1
1.2
iu/l
25.1
19.3
—
10
55
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
88
2.18
2.52
1.1
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
12
5.02
2.40
1.3
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
77
546
1.44
2.35
2.0
1.9
ug/l
1.2
2.7
0.80
68
485
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
60
406
1.51
2.32
4.4
3.7
u/ml
80.1
10090.6
0.84
52
345
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
322
2792
1.22
2.28
3.0
3.4
u/l
46.5
35.5
0.50
295
2652
(40768800) Prostate Pathology biopsy report
60
408
1.50
2.27
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
285
2447
1.22
2.22
3.7
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
80
580
1.41
2.18
3.1
3.4
e9/l
4.5
4.2
0.34
53
425
(40760892) CBC W Ordered Manual Differential panel - Blood
209
1739
1.25
2.17
5.1
4.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
23
122
1.90
2.17
1.5
1.7
mu/l
321.1
289.7
0.12
23
114
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
74
530
1.43
2.16
2.7
2.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
223
1872
1.24
2.14
4.1
3.2
mmol/l
2.5
2.5
0.87
198
1635
(40768806) Pleura Pathology biopsy report
28
160
1.77
2.11
1.6
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
49
2.47
2.11
1.2
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
49
2.47
2.11
1.2
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
27
153
1.78
2.09
1.5
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
251
2141
1.23
2.07
1.9
1.8
nmol/l
1120.5
1141.9
0.13
173
1625
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
117
1.90
2.07
1.7
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
360
1.50
2.04
2.8
3.5
pmol/l
4.3
4.3
0.11
48
310
(40768441) Liver Pathology biopsy report
14
63
2.24
2.01
1.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
63
2.24
2.01
1.9
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
151
1226
1.27
1.94
5.0
4.9
%
32.8
32.3
0.27
92
817
(3037121) Protein [Mass/volume] in Urine
56
390
1.46
1.92
3.2
2.9
g/l
0.4
0.3
0.46
30
161
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
78
2.07
1.91
1.1
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
58
2.26
1.91
1.2
1.4
promille
2.0
1.2
—
8
45
(3000494) Fungus identified in Specimen by Culture
136
1095
1.28
1.87
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
37
237
1.58
1.86
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
37
237
1.58
1.86
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
28
2.87
1.86
1.1
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
79
590
1.37
1.84
1.6
1.9
g/l
1.7
1.5
1.13
71
507
(40757373) Influenza virus identified in Isolate
7
23
3.06
1.80
2.6
1.5
—
—
—
0
0
(3000492) Spirometry study
92
707
1.33
1.79
1.6
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
268
2335
1.20
1.77
1.6
1.6
mmol/l
1.4
1.3
0.89
204
1909
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
131
1062
1.27
1.72
2.8
2.5
ug/l
6.5
7.3
0.24
115
947
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
48
0.00
1.70
0.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
708
6689
1.17
1.70
33.2
24.2
g/l
331.0
332.5
3.79
700
6642
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
211
1.58
1.69
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
98
1.85
1.62
1.4
2.4
ml
852.9
646.3
—
7
61
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
32
2.51
1.60
5.4
2.9
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
37
247
1.52
1.59
2.1
3.6
u/ml
455.2
1348.2
0.39
32
232
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
85
1.90
1.55
1.3
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
64
2.04
1.54
1.2
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
64
2.04
1.54
1.2
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
43
300
1.45
1.51
11.2
4.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
72
1.96
1.49
1.6
2.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
95
755
1.28
1.48
1.6
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
21
124
1.71
1.48
1.5
1.5
%
61.8
65.4
0.14
13
83
(3004809) Band form neutrophils/100 leukocytes in Blood
30
195
1.55
1.47
3.9
4.2
%
0.8
1.4
0.85
20
153
(3021788) Differential panel - Synovial fluid
28
179
1.58
1.47
1.7
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
66
1.98
1.43
3.2
2.9
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
47
2.14
1.34
3.8
3.1
u/l
255.9
217.6
—
10
47
(3042733) HLA Ab [Presence] in Serum
6
24
2.51
1.30
2.2
4.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
34
2.36
1.29
2.1
2.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
178
1.53
1.27
1.6
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
52
389
1.35
1.27
1.2
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
123
1.64
1.24
4.8
2.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.5
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
13
70
1.87
1.24
1.4
2.3
min
538.6
494.5
—
5
47
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
34
237
1.45
1.24
2.4
2.5
%
219.8
206.3
0.36
34
223
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
163
1.55
1.24
1.4
1.5
e6/l
17366.8
68273.5
1.19
15
98
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
147
1.58
1.23
1.6
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
172
1.52
1.21
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
246
2196
1.16
1.20
8.4
6.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
149
1.56
1.18
2.5
2.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
22
141
1.57
1.18
5.4
6.8
mmol/l
7.7
7.2
0.31
17
117
(3000012) Reticulocyte production index
11
57
1.94
1.17
1.1
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
20
2.51
1.15
1.0
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
20
126
1.60
1.15
1.2
1.1
iu/ml
1.0
32.5
—
5
27
(4034850)
19
295
0.64
1.14
17.3
12.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
37
268
1.39
1.12
3.8
3.5
mmol/l
1.7
1.6
0.46
37
262
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
932
1.21
1.11
2.2
2.2
nmol/l
10.1
12.6
2.96
96
803
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
51
1.97
1.11
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
38
277
1.39
1.11
1.3
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
17
104
1.64
1.09
1.2
1.3
u/l
12.9
13.2
0.03
17
99
(3036048) Francisella tularensis Ab [Titer] in Serum
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
218
0.59
1.08
1.5
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
193
0.57
1.08
1.1
1.2
—
5.2
—
0
16
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
229
1.41
1.04
1.5
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
98
1.64
1.03
1.2
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
196
1.44
1.03
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
91
1.66
1.01
2.3
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
131
1.54
1.00
3.2
4.3
%
63.0
55.9
—
10
86
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
49
1.84
0.98
5.9
4.2
nmol/l
78.4
97.8
—
9
49
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
232
1.39
0.98
1.5
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
23
2.18
0.98
2.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
140
1.51
0.98
1.0
1.2
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
29
0.00
0.98
0.0
1.6
—
23.9
—
0
24
(4024509)
15
92
1.64
0.97
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
143
0.56
0.93
1.4
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
235
1.37
0.92
5.2
3.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
134
1.50
0.92
5.7
4.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
45
349
1.30
0.91
1.3
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
28
2.15
0.91
1.5
2.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
86
1.64
0.91
2.3
1.9
u/field
1.1
1.8
—
8
29
(3038515) Glucose [Moles/volume] in Venous blood
34
253
1.36
0.91
4.1
3.6
mmol/l
7.8
7.7
0.07
34
248
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
102
1.58
0.90
1.3
1.4
u/l
15.6
13.7
0.22
16
97
(3019977) pH of Arterial blood
12
71
1.70
0.89
1.9
3.5
ph
7.4
7.4
—
5
24
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
42
1.91
0.88
2.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
64
1.73
0.86
1.8
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
34
256
1.34
0.85
1.5
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
45
1.78
0.84
1.5
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
154
1.44
0.83
3.6
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
232
1.35
0.82
1.5
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
18
259
0.69
0.80
1.3
3.1
umol/l
24.4
34.1
3.19
12
211
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
164
0.61
0.80
1.1
1.1
—
1.8
—
0
8
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
225
1.34
0.78
5.8
4.0
mg/l
30.2
30.4
0.01
19
146
(3037522) Nuclear Ab [Titer] in Serum
112
977
1.16
0.78
1.2
1.3
titre
327.3
452.5
0.92
22
221
(4146454)
19
132
1.45
0.76
2.3
2.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
17
244
0.69
0.76
1.1
1.2
—
1440.0
—
0
8
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
150
1.41
0.73
1.7
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
38
1.85
0.73
6.9
7.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
106
0.56
0.72
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
39
1.80
0.72
2.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
39
1.80
0.72
2.0
3.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
53
435
1.23
0.72
4.0
3.8
mmol/l
1.3
1.4
0.18
53
428
(3000475) Leukocytes [#/volume] in Synovial fluid
33
256
1.30
0.71
1.7
1.7
e6/l
13948.3
16127.2
0.19
23
188
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
3.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
87
753
1.17
0.68
7.3
6.9
mmol/l
24.2
24.4
0.14
82
695
(3024471) HLA-A [Type]
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
44
357
1.24
0.67
5.2
6.5
mmol/l
1.3
1.4
0.74
39
304
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
28
1.79
0.66
3.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
28
1.79
0.66
4.6
6.0
%
13.4
13.3
—
5
28
(3023199) Leukocytes [#/volume] in Pleural fluid
24
180
1.34
0.65
1.5
1.5
e6/l
1428.4
1623.2
0.13
18
127
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
u/ml
—
24.8
—
0
5
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
88
768
1.16
0.63
1.2
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
64
544
1.19
0.63
4.7
4.1
%
48.5
47.5
0.13
64
537
(40760888) Immunoglobulin light chains.free panel - Serum
38
306
1.25
0.63
2.7
3.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
176
0.68
0.62
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
96
1.46
0.61
2.4
1.2
u/ml
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
165
1.34
0.60
1.6
2.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
317
1.24
0.60
1.2
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
183.0
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
201
1.30
0.59
1.1
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
64
1.57
0.58
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
1.2
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
328
1.23
0.58
1.1
1.2
iu/ml
158.4
150.8
—
9
112
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
196
0.71
0.57
1.4
1.2
mmol/l
4.1
4.0
0.13
14
178
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
54
1.49
0.57
2.8
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
81
1.49
0.57
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
167
1.32
0.57
3.0
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
14
195
0.71
0.56
1.9
1.3
e6/l
1310.7
813.0
—
9
160
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
14
195
0.71
0.56
1.8
1.3
e6/l
18.9
49.5
—
9
157
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
229
0.74
0.56
1.3
1.2
mg/l
791.3
549.3
0.56
17
210
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
248
1.26
0.55
1.7
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
168
1.32
0.55
4.5
2.9
u/ml
23.8
61.7
0.87
22
162
(3037756) Immunofixation for Serum or Plasma
33
267
1.24
0.54
1.3
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
61
1.48
0.53
3.3
3.6
—
—
—
0
0
(4015189)
6
40
1.50
0.51
2.2
1.9
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
40
1.50
0.51
1.2
1.3
%
35.3
26.0
—
6
27
(3044290) Cell count panel - Cerebral spinal fluid
13
180
0.72
0.51
1.8
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
84
745
1.14
0.51
1.9
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
84
1.43
0.49
1.3
1.2
nmol/l
1.2
1.5
0.66
12
75
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
144
0.69
0.49
1.1
1.1
g/l
1.3
1.6
—
10
133
(21494755) Public health laboratory ask at order entry panel
24
301
0.79
0.49
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
262
1.23
0.49
1.4
1.5
ug/g
238.6
259.9
0.25
17
165
(3011288) Drugs identified in Urine by Screen method
7
46
1.53
0.48
1.0
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
111
0.63
0.48
1.7
2.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
85
1.42
0.47
1.4
1.8
%
10.0
10.8
0.20
12
85
(3019060) Gas panel - Arterial blood
90
808
1.12
0.47
4.9
4.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
133
1222
1.10
0.46
8.0
8.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(44806420)
7
49
1.43
0.46
2.3
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
183
1.26
0.45
1.9
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
405
1.17
0.44
4.2
3.7
mg/l
89.7
89.6
0.00
34
336
(3034860) Kappa light chains.free [Mass/volume] in Serum
47
405
1.17
0.44
4.2
3.7
mg/l
50.4
75.6
0.82
34
333
(3036782) Glucose [Moles/volume] in Pleural fluid
18
139
1.30
0.44
1.6
1.5
mmol/l
7.3
6.6
0.59
18
131
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
46
396
1.17
0.43
4.3
3.7
ratio
1.1
2.0
—
6
33
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
56
1.43
0.42
1.0
1.2
nmol/l
—
7.0
—
0
11
(3045788) Cell count panel - Pleural fluid
18
140
1.29
0.42
1.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.8
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
16.1
—
0
16
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
740
1.12
0.40
4.7
4.1
ng/l
112.1
101.8
0.36
66
641
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
34
1.47
0.40
67.8
32.0
ug/l
6.2
7.1
—
5
29
(3051593) INR in Capillary blood by Coagulation assay
8
60
1.34
0.40
3.1
16.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
89
808
1.11
0.40
2.8
2.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
251
1.20
0.39
1.6
1.5
iu/ml
1.4
25.4
—
9
53
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
160
1.25
0.38
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
261
1.19
0.38
1.8
1.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
25
206
1.22
0.38
1.2
1.2
u/l
49.8
56.1
0.08
25
181
(3003327) Ova and parasites identified in Stool by Light microscopy
16
203
0.78
0.38
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
735
1.11
0.37
1.9
1.6
—
—
—
0
0
(4281824)
9
69
1.31
0.37
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
115
0.69
0.37
1.8
2.0
—
—
—
0
0
(4062490)
9
70
1.29
0.36
1.8
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
29
244
1.19
0.36
1.2
1.2
—
0.9
—
0
25
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
460
1.14
0.36
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
81
1.36
0.36
1.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
9
71
1.27
0.36
1.0
1.5
—
241.4
—
0
7
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
153
1.25
0.35
1.8
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
156
0.77
0.34
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
361
0.85
0.34
2.0
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
221
0.81
0.33
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
264
0.83
0.33
1.1
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
131
0.76
0.31
1.2
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
147
1.23
0.31
1.7
2.6
mg/l
13.2
20.0
—
5
35
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
229
0.83
0.30
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
37
325
1.14
0.30
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
51
460
1.11
0.28
5.1
4.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
118
0.76
0.27
2.7
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
131
1.22
0.27
2.4
4.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
65
1.23
0.27
1.9
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
12
95
1.27
0.26
1.2
1.3
%
14.7
26.4
—
7
63
(21494890) Protein electrophoresis panel - 24 hour Urine
11
138
0.79
0.25
1.5
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
73
1.23
0.25
2.2
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
234
0.85
0.25
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
234
0.85
0.25
1.8
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
38
422
0.90
0.23
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
147
0.81
0.23
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
232
0.86
0.23
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
274
0.87
0.22
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
91
0.77
0.22
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
410
1.10
0.22
3.5
2.7
g/l
3.2
3.1
0.02
31
323
(3033799) Differential panel - Peritoneal fluid
5
42
1.19
0.21
2.0
2.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
5.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.7
u/ml
620.6
1486.7
—
5
43
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
42
383
1.10
0.21
4.3
2.9
g/l
1.4
1.5
0.11
30
335
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
40
364
1.10
0.20
4.9
4.0
mmol/l
4.0
4.0
0.03
33
333
(3020630) Protein [Mass/volume] in Serum or Plasma
102
970
1.06
0.19
2.8
2.9
g/l
65.9
66.0
0.07
90
889
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
81
1.24
0.18
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
77
816
0.94
0.18
1.2
1.8
%
1.7
1.7
0.24
62
672
(1175426) CD3 cells/100 lymphocytes in Blood
7
58
1.21
0.18
1.4
2.3
%
70.7
70.5
—
7
52
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
60
1.17
0.18
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
60
1.17
0.18
1.6
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
157
1.15
0.17
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
288
0.90
0.16
1.1
1.2
—
—
—
0
0
(4268621)
5
70
0.71
0.16
2.8
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
9
79
1.14
0.15
1.8
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
9
82
1.10
0.15
1.0
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
107
1029
1.04
0.14
3.7
3.1
ng/l
319.2
241.9
0.83
100
936
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
139
0.86
0.14
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
122
1.15
0.13
1.4
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
98
0.81
0.13
2.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
443
1.06
0.12
3.4
2.7
g/l
7.5
7.3
0.25
31
329
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
443
1.06
0.12
3.4
2.7
g/l
3.9
3.9
0.07
31
318
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
443
1.06
0.12
3.4
2.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
124
1.13
0.11
1.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
124
1.13
0.11
1.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
121
1175
1.03
0.11
1.2
1.3
iu/ml
24.1
45.0
1.78
32
361
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
156
0.90
0.10
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
44
1.14
0.10
3.8
3.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
47
1.06
0.09
2.6
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
90
872
1.04
0.09
1.8
1.5
—
—
—
0
0
(4211845)
5
48
1.04
0.09
3.8
3.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(4094501)
22
237
0.93
0.09
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
54
1.11
0.09
1.5
3.0
mmol/l
10.7
9.3
—
6
45
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
62
0.81
0.08
1.8
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
65
1.08
0.08
2.6
2.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
6
71
0.84
0.07
1.0
1.2
%
93.3
95.7
—
6
66
(3016038) Potassium [Moles/volume] in Urine
6
70
0.86
0.07
1.0
1.2
mmol/l
30.3
35.1
—
6
63
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
78
1.03
0.07
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
147
1.09
0.07
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
194
0.93
0.07
1.4
1.3
nmol/l
1.2
0.8
1.02
12
155
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
82
0.85
0.07
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
84
0.83
0.07
2.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
146
1433
1.02
0.07
1.2
1.2
u/ml
2.1
1.4
0.30
29
353
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
92
0.87
0.06
1.6
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
8
93
0.86
0.06
1.8
2.0
mg/l
3.4
4.7
—
8
88
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
95
0.84
0.06
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
136
1384
0.98
0.06
1.6
1.5
g/l
3.2
3.0
0.23
83
819
(3013139) Helicobacter pylori Ag [Presence] in Stool
51
493
1.04
0.06
1.1
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
414
1.04
0.06
3.7
2.8
g/l
10.3
10.8
0.38
32
353
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
178
1.07
0.05
4.1
3.1
%
57.3
59.9
0.30
19
178
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
208
1.06
0.05
1.3
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
15
161
0.93
0.05
1.3
1.4
—
20.4
—
0
5
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
24
252
0.95
0.05
1.3
1.7
nmol/l
43.0
44.7
0.15
24
236
(36660697) Celiac disease serology panel - Serum
52
507
1.03
0.04
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
230
1.04
0.03
1.4
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
171
1.05
0.03
3.7
2.8
e9/l
5.0
4.6
0.24
18
171
(4010399)
68
668
1.02
0.03
1.5
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
148
0.95
0.02
1.1
1.2
u/ml
282.6
320.1
—
5
78
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
80
789
1.02
0.02
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
113
1.06
0.02
1.4
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
13
137
0.95
0.01
1.3
1.4
u/ml
105.7
138.3
—
6
22
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
24
233
1.03
0.01
1.5
1.8
mg/l
10.4
12.3
0.40
18
212
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
30
307
0.98
0.01
4.7
2.8
g/l
0.0
0.0
0.00
25
285
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
124
1.05
0.00
1.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
124
1.05
0.00
1.4
1.6
—
—
—
0
0
(4306422)
10
96
1.04
0.00
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
114
0.96
0.00
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
146
1.03
0.00
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
21
206
1.02
0.00
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
35
346
1.01
0.00
4.2
2.7
g/l
35.3
37.0
0.76
26
300
(3000093) Morphology [Interpretation] in Blood Narrative
11
112
0.98
0.00
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
138
1.01
0.00
1.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
162
0.99
0.00
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
73
726
1.01
0.00
2.3
2.2
ug/g
155.4
163.2
0.06
53
571
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
192
0.99
0.00
1.2
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
33
328
1.01
0.00
4.4
2.8
g/l
0.4
0.0
0.64
28
306
(44790049)
12
121
0.99
0.00
2.1
1.5
—
—
—
0
0
(44790048)
12
121
0.99
0.00
2.1
1.5
—
—
—
0
0
(44790047)
12
121
0.99
0.00
2.1
1.5
—
—
—
0
0
(44806118)
12
121
0.99
0.00
2.1
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
129
1.01
0.00
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
97
1.03
0.00
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
24
243
0.99
0.00
1.3
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
373
0.99
0.00
1.4
1.7
u/l
36.6
37.4
0.10
29
321
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
112
1125
1.00
0.00
1.2
1.2
u/ml
6.0
15.9
1.65
29
395
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
155
0.97
0.00
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
175
0.97
0.00
1.5
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
145
0.97
0.00
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
125
1.04
0.00
1.4
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
23.1
—
0
9
(3016879) Cocaine [Presence] in Urine
7
69
1.01
0.00
1.0
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
69
1.01
0.00
1.0
1.6
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
74
0.95
0.00
5.7
3.2
u/ml
78.3
26.2
—
7
74
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
55
0.91
0.00
4.0
2.6
e9/l
0.3
0.2
—
5
50
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
89
1.01
0.00
1.9
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
70
1.00
0.00
1.0
1.5
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
935.7
—
0
6
(3028300) Cannabinoids [Presence] in Urine
7
71
0.99
0.00
1.0
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
71
0.99
0.00
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
57
0.88
0.00
1.0
1.6
u/l
—
10.4
—
0
30
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
54
0.93
0.00
1.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
75
0.93
0.00
1.6
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
59
0.85
0.00
1.4
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
57
0.88
0.00
4.0
2.5
e6/l
816.8
586.6
—
5
50
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
70
1.00
0.00
1.1
1.1
mmol/l
2.3
2.0
—
7
64
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
54
0.93
0.00
1.4
2.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.3
—
0
6
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
71
0.99
0.00
1.0
1.5
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.3
—
0.2
—
0
8
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
419.6
—
0
5
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
70
1.00
0.00
1.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
68
0.88
0.00
10.8
3.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
75
0.93
0.00
1.6
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
66
0.91
0.00
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BLADDER – Carcinoma in situ, bladder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).